EVECXIA THERAPEUTICS Trademark

Trademark Overview

On Monday, December 14, 2020, a trademark application was filed for EVECXIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EVECXIA THERAPEUTICS trademark a serial number of 90380606. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Thursday, October 10, 2024. This trademark is owned by Evecxia Therapeutics, Inc.. The EVECXIA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; research and development of pharmaceuticals for the treatment of neuropsychiatric conditions, depression and central nervous system disorders; pharmaceutical drug development services in the field of neuropsychiatric conditions, depression and central nervous system disorders
evecxia therapeutics

General Information

Serial Number90380606
Word MarkEVECXIA THERAPEUTICS
Filing DateMonday, December 14, 2020
Status645 - FINAL REFUSAL - MAILED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development; research and development of pharmaceuticals for the treatment of neuropsychiatric conditions, depression and central nervous system disorders; pharmaceutical drug development services in the field of neuropsychiatric conditions, depression and central nervous system disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 22, 2021
Primary Code042
First Use Anywhere DateWednesday, September 30, 2020
First Use In Commerce DateWednesday, September 30, 2020

Trademark Owner History

Party NameEvecxia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Trademark Events

Event DateEvent Description
Saturday, June 5, 2021ASSIGNED TO EXAMINER
Thursday, December 17, 2020NEW APPLICATION ENTERED
Monday, February 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 14, 2021NON-FINAL ACTION WRITTEN
Monday, June 14, 2021NON-FINAL ACTION E-MAILED
Monday, June 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 27, 2021SUSPENSION LETTER WRITTEN
Wednesday, October 27, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, October 27, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 31, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 30, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, March 9, 2023NON-FINAL ACTION WRITTEN
Thursday, March 9, 2023NON-FINAL ACTION E-MAILED
Thursday, March 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 16, 2023ASSIGNED TO EXAMINER
Friday, June 23, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, June 23, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, June 23, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, August 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 22, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, August 22, 2023PETITION TO REVIVE-GRANTED
Tuesday, August 22, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, August 22, 2023NOTICE OF REVIVAL - E-MAILED
Friday, January 12, 2024ASSIGNED TO LIE
Friday, January 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024NON-FINAL ACTION WRITTEN
Thursday, February 29, 2024NON-FINAL ACTION E-MAILED
Thursday, February 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, August 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 10, 2024FINAL REFUSAL WRITTEN
Thursday, October 10, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 10, 2024FINAL REFUSAL E-MAILED
Wednesday, May 29, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, August 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE

Related Keywords

therapeutics evecxia development central nervous system pharmaceutical disorders depression research neuropsychiatric conditions